Cargando…

Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy

BACKGROUND: Therapeutic regimens designed to augment the immunological response of a patient with breast cancer (BC) to tumor tissue are critically informed by tumor mutational burden and the antigenicity of expressed neoepitopes. Herein we describe a neoepitope and cognate neoepitope-reactive T-cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reimann, Hannah, Nguyen, Andrew, Sanborn, J Zachary, Vaske, Charles J, Benz, Stephen C, Niazi, Kayvan, Rabizadeh, Shahrooz, Spilman, Patricia, Mackensen, Andreas, Ruebner, Matthias, Hein, Alexander, Beckmann, Matthias W, van der Meijden, Edith D, Bausenwein, Judith, Kretschmann, Sascha, Griffioen, Marieke, Schlom, Jeffrey, Gulley, James L, Lee, Karin L, Hamilton, Duane H, Soon-Shiong, Patrick, Fasching, Peter A, Kremer, Anita N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237736/ https://www.ncbi.nlm.nih.gov/pubmed/34172517 http://dx.doi.org/10.1136/jitc-2021-002605

Ejemplares similares

Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM
por: Sedgewick, Andrew J., et al.
Publicado: (2013)

Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples
por: Givechian, Kevin B., et al.
Publicado: (2018)

Combination therapies utilizing neoepitope-targeted vaccines
por: Lee, Karin L., et al.
Publicado: (2020)

Comprehensive genomic transcriptomic tumor-normal gene panel analysis for enhanced precision in patients with lung cancer
por: Rabizadeh, Shahrooz, et al.
Publicado: (2018)

PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
por: Fabian, Kellsye P, et al.
Publicado: (2020)

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
por: Bilusic, Marijo, et al.
Publicado: (2021)

A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival
por: Jaber, Mustafa I., et al.
Publicado: (2020)

Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management
por: Marté, Jennifer L, et al.
Publicado: (2020)

Deep Learning Implicitly Handles Tissue Specific Phenomena to Predict Tumor DNA Accessibility and Immune Activity
por: Wnuk, Kamil, et al.
Publicado: (2019)

Large scale, robust, and accurate whole transcriptome profiling from clinical formalin-fixed paraffin-embedded samples
por: Newton, Yulia, et al.
Publicado: (2020)

Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression
por: Givechian, Kevin B, et al.
Publicado: (2020)

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants
por: Tanaka, Shiho, et al.
Publicado: (2021)

An immunogenic NSCLC microenvironment is associated with favorable survival in lung adenocarcinoma
por: Givechian, Kevin B., et al.
Publicado: (2019)

Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens
por: Bernhardt, Anna Luise, et al.
Publicado: (2021)

Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
por: Tanaka, Shiho, et al.
Publicado: (2022)

Overcoming hypoxia-induced functional suppression of NK cells
por: Solocinski, Kristen, et al.
Publicado: (2020)

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice
por: Rice, Adrian, et al.
Publicado: (2021)

Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase
por: Kremer, Anita N., et al.
Publicado: (2020)

IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS
por: Eyrich, Matthias, et al.
Publicado: (2020)

IMMU-08. reMATCH PROTOCOL: PHASE II STUDY OF EX-VIVO EXPANDED AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (X-ALT) + TOTAL TUMOR RNA DC VACCINE (TT-RNA DC) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND PERIPHERAL BLOOD STEM CELL (PBSC) RESCUE OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) AND PBSC IN PATIENTS (PTS) WITH RECURRENT PNET (R-PNET)
por: Gururangan, Sridharan, et al.
Publicado: (2020)

IMMU-07. Interim analysis of the HIT-HGG Rez Immunvac study - Dendritic cell vaccination with partial T(reg) depletion and double checkpoint blockade in children with relapsed high-grade gliomas.
por: Eyrich, Matthias, et al.
Publicado: (2022)

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
por: Redman, Jason M., et al.
Publicado: (2022)

Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
por: Redman, Jason M., et al.
Publicado: (2023)

Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa
por: Tsai, Yo-Ting, et al.
Publicado: (2022)

CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma
por: Givechian, Kevin B., et al.
Publicado: (2018)

The neoepitope landscape in pediatric cancers
por: Chang, Ti-Cheng, et al.
Publicado: (2017)

Pan-cancer analysis of neoepitopes
por: Teku, Gabriel N., et al.
Publicado: (2018)

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2015)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer
por: Gao, Yang, et al.
Publicado: (2016)

Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis
por: Dahut, Madeline, et al.
Publicado: (2023)

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
por: Gabitzsch, Elizabeth, et al.
Publicado: (2021)

Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
por: Fasching, Peter A., et al.
Publicado: (2023)

NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
por: Becker, Jonas P., et al.
Publicado: (2021)

Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis
por: Robbins, Yvette, et al.
Publicado: (2021)

Accumulation of T-cell-suppressive PD-L1(high) extracellular vesicles is associated with GvHD and might impact GvL efficacy
por: Baur, Rebecca, et al.
Publicado: (2023)

DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2016)

IMMU-13. CUSTOMIZABLE MULTI-LAMELLAR RNA-NANOPARTICLES FOR PEDIATRIC GLIOMA
por: Mendez-Gomez, Hector, et al.
Publicado: (2021)

Intron retention is a source of neoepitopes in cancer
por: Smart, Alicia C., et al.
Publicado: (2018)

The neoepitope landscape of breast cancer: implications for immunotherapy
por: Narang, Pooja, et al.
Publicado: (2019)

Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery
por: de Sousa, Eric, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k5m6ohbce4lako0nmfscgaqvd0